Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

With respect to the ketogenic diet, Anekwe et al. (61) report on a patient with obesity who self-administered the diet (described as consuming predominantly eggs, cheese, butter, oil, nuts, leafy green vegetables and almond/coconut milk; 61) for three months; around this period, aspartate aminotransferase (AST) rose from 21 U/L to 67 U/L, alanine aminotransferase (ALT) from 18 U/L to 119 U/L, and low-density lipoprotein-cholesterol (LDL-C) from 156 mg/dL to 209 mg/dL, high-density lipoprotein-cholesterol (HDL-C) decreased from 102 mg/dL to 98 mg/dL, and a vitamin D deficiency was also noted.

Source: Safety analysis. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Review / evidence synthesis.

Review / evidence synthesis

Reviews existing research; the exact review methods need further assessment.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Ketogenic therapy as a potential novel treatment approach for PTSD: an integrative review and proposed mechanistic model

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Ketogenic therapy as a potential novel treatment approach for PTSD: an integrative review and proposed mechanistic model

Review / evidence synthesis · Frontiers in Psychiatry · 2026

Original publication title

Ketogenic therapy as a potential novel treatment approach for PTSD: an integrative review and proposed mechanistic model

Robin Engelhardt; John O. Ogedengbe; Malvina S. Millet; Mira E. G. Ayad; Inga Schalinski; Timo Von Oertzen; Anna Rieckmann; David Effinger; Simon Hirschberger; Christopher M. Palmer; Georgia Ede; Shane W. Kraus; Dominik Trommer; Louis Schreel; Julia Tulipan; Bailey Way; Roman-Ulrich Müller; Allison Hull; Jürgen Maes; Marc N. Potenza

Copyright © 2026 Engelhardt, Ogedengbe, Millet, Ayad, Schalinski, Von Oertzen, Rieckmann, Effinger, Hirschberger, Palmer, Ede, Kraus, Trommer, Schreel, Tulipan, Way, Müller, Hull, Maes and Potenza.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: What background does the paper provide?

Brain and body metabolic disruptions have been suggested in several studies as a mechanism underlying posttraumatic stress disorder (PTSD). Therapies targeting metabolic pathways might provide new treatment options. This review explores the potential of ketogenic therapies, such as the ketogenic diet and ketone supplementation, as novel metabolic treatments for PTSD.

Source: Background

Abstract: What methods does the paper describe?

An integrative review was conducted. We searched PubMed, Scopus, PsycINFO, PsycArticles, PSYNDEX, MEDLINE, ClinicalTrials.gov, International Clinical Trials Registry Platform, and EU Clinical Trials Register for clinical, preclinical, observational, mechanistic, and review studies that reported outcomes or mechanisms on the intersection of ketogenic therapy and PTSD. Methodological quality of included studies was assessed independently by two reviewers based on predefined criteria.

Source: Methods

Abstract: Discussion

Importantly, the absence of larger clinical trials and the reliance on low-level evidence substantially limit current interpretations. High-quality randomized and adequately powered clinical trials are required to examine the potential role of ketogenic therapies in treating PTSD.

Source: Discussion

Abstract: Results

Sixteen articles (9 human, 4 animal studies, 3 reviews) were eligible and included in the present review. Several metabolic and signaling pathways through which ketogenic therapies could impact PTSD pathophysiology were identified. Preclinical data suggestive of potential efficacy were identified, while only minimal reliable information is available from human studies.

Source: Results
Authors’ abstract

Background

Brain and body metabolic disruptions have been suggested in several studies as a mechanism underlying posttraumatic stress disorder (PTSD). Therapies targeting metabolic pathways might provide new treatment options. This review explores the potential of ketogenic therapies, such as the ketogenic diet and ketone supplementation, as novel metabolic treatments for PTSD.

Methods

An integrative review was conducted. We searched PubMed, Scopus, PsycINFO, PsycArticles, PSYNDEX, MEDLINE, ClinicalTrials.gov, International Clinical Trials Registry Platform, and EU Clinical Trials Register for clinical, preclinical, observational, mechanistic, and review studies that reported outcomes or mechanisms on the intersection of ketogenic therapy and PTSD. Methodological quality of included studies was assessed independently by two reviewers based on predefined criteria.

Results

Sixteen articles (9 human, 4 animal studies, 3 reviews) were eligible and included in the present review. Several metabolic and signaling pathways through which ketogenic therapies could impact PTSD pathophysiology were identified. Preclinical data suggestive of potential efficacy were identified, while only minimal reliable information is available from human studies.

Discussion

Importantly, the absence of larger clinical trials and the reliance on low-level evidence substantially limit current interpretations. High-quality randomized and adequately powered clinical trials are required to examine the potential role of ketogenic therapies in treating PTSD.

Publication and source details

Original title: Ketogenic therapy as a potential novel treatment approach for PTSD: an integrative review and proposed mechanistic model

Robin Engelhardt; John O. Ogedengbe; Malvina S. Millet; Mira E. G. Ayad; Inga Schalinski; Timo Von Oertzen; Anna Rieckmann; David Effinger; Simon Hirschberger; Christopher M. Palmer; Georgia Ede; Shane W. Kraus; Dominik Trommer; Louis Schreel; Julia Tulipan; Bailey Way; Roman-Ulrich Müller; Allison Hull; Jürgen Maes; Marc N. Potenza

Frontiers in Psychiatry · 2026

* Correspondence: Robin Engelhardt, robin.engelhardt@unibw.deCopyright © 2026 Engelhardt, Ogedengbe, Millet, Ayad, Schalinski, Von Oertzen, Rieckmann, Effinger, Hirschberger, Palmer, Ede, Kraus, Trommer, Schreel, Tulipan, Way, Müller, Hull, Maes and Potenza.2026Engelhardt, Ogedengbe, Millet, Ayad, Schalinski, Von Oertzen, Rieckmann, Effinger, Hirschberger, Palmer, Ede, Kraus, Trommer, Schreel, Tulipan, Way, Müller, Hull, Maes and Potenzahttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. JM and RE were funded by dtec.bw: Digitalization and Technology Research Center of the Bundeswehr. dtec.bw is funded by the European Union: NextGenerationEU. SK was supported by the Kindbridge Research Institute. CP receives philanthropic funding for the Metabolic and Mental Health Program. R-UM is supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), the Marga and Walter Boll-Foundation, the Jörg Bernards-Foundation, the Federal Ministry of Research, Technology and Space and the European Union (OSCARS). We acknowledge financial support by Universität der Bundeswehr München.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:42:20.865459+00:00

DOI: 10.3389/fpsyt.2026.1854499 · PMC13598748